219 related articles for article (PubMed ID: 34119434)
21. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.
Sutlu T; Nyström S; Gilljam M; Stellan B; Applequist SE; Alici E
Hum Gene Ther; 2012 Oct; 23(10):1090-100. PubMed ID: 22779406
[TBL] [Abstract][Full Text] [Related]
23. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.
Suerth JD; Morgan MA; Kloess S; Heckl D; Neudörfl C; Falk CS; Koehl U; Schambach A
J Mol Med (Berl); 2016 Jan; 94(1):83-93. PubMed ID: 26300042
[TBL] [Abstract][Full Text] [Related]
24. Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.
Mendenhall A; Lesnik J; Mukherjee C; Antes T; Sengupta R
J Vis Exp; 2012 Apr; (62):e3171. PubMed ID: 22508377
[TBL] [Abstract][Full Text] [Related]
25. Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing
Allan DSJ; Chakraborty M; Waller GC; Hochman MJ; Poolcharoen A; Reger RN; Childs RW
Mol Ther Methods Clin Dev; 2021 Mar; 20():559-571. PubMed ID: 33665226
[TBL] [Abstract][Full Text] [Related]
26. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
[TBL] [Abstract][Full Text] [Related]
27. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus.
Finkelshtein D; Werman A; Novick D; Barak S; Rubinstein M
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7306-11. PubMed ID: 23589850
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.
Sandrin V; Boson B; Salmon P; Gay W; Nègre D; Le Grand R; Trono D; Cosset FL
Blood; 2002 Aug; 100(3):823-32. PubMed ID: 12130492
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells.
Tran J; Kung SK
Mol Ther; 2007 Jul; 15(7):1331-9. PubMed ID: 17505478
[TBL] [Abstract][Full Text] [Related]
31. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
32. Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.
Kim YS; Wielgosz MM; Hargrove P; Kepes S; Gray J; Persons DA; Nienhuis AW
Mol Ther; 2010 Jul; 18(7):1310-7. PubMed ID: 20372106
[TBL] [Abstract][Full Text] [Related]
33. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
Frecha C; Costa C; Nègre D; Gauthier E; Russell SJ; Cosset FL; Verhoeyen E
Blood; 2008 Dec; 112(13):4843-52. PubMed ID: 18812471
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor.
Gong Y; Klein Wolterink RGJ; Janssen I; Groot AJ; Bos GMJ; Germeraad WTV
Mol Ther Methods Clin Dev; 2020 Jun; 17():634-646. PubMed ID: 32300610
[TBL] [Abstract][Full Text] [Related]
35. A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy.
Bari R; Granzin M; Tsang KS; Roy A; Krueger W; Orentas R; Schneider D; Pfeifer R; Moeker N; Verhoeyen E; Dropulic B; Leung W
Front Immunol; 2019; 10():2001. PubMed ID: 31507603
[TBL] [Abstract][Full Text] [Related]
36. Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors.
Frank AM; Braun AH; Scheib L; Agarwal S; Schneider IC; Fusil F; Perian S; Sahin U; Thalheimer FB; Verhoeyen E; Buchholz CJ
Blood Adv; 2020 Nov; 4(22):5702-5715. PubMed ID: 33216892
[TBL] [Abstract][Full Text] [Related]
37. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
38. Introduction of shRNAs into primary NK cells with lentivirus.
Kung SK
Methods Mol Biol; 2010; 612():233-47. PubMed ID: 20033645
[TBL] [Abstract][Full Text] [Related]
39. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
40. Retargeting vesicular stomatitis virus glycoprotein pseudotyped lentiviral vectors with enhanced stability by in situ synthesized polymer shell.
Liang M; Yan M; Lu Y; Chen IS
Hum Gene Ther Methods; 2013 Feb; 24(1):11-8. PubMed ID: 23327104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
